News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
Presentation TCT 2023 TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry Presenter: Matthew Li Kam Wa October 26, 2023
Presentation TCT 2023 TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials Presenter: Usman Naseer October 25, 2023
Presentation TCT 2023 Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial Presenter: Juan Iglesias October 25, 2023
Presentation TCT 2023 Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial Presenter: Giovanni Esposito October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
Presentation TCT 2023 Twelve-Month Follow-Up Outcomes of a Prospective, Multi-Center, Open, Single-Arm Study of the First Everolimus-Coated Balloon for the Treatment of Coronary In-Stent Restenosis Presenter: Manel Sabate October 24, 2023
News Conference News ESC 2023 STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI Todd Neale August 26, 2023
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Daily News Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis Michael O'Riordan February 24, 2023
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
Presentation TCT 2022 Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial Presenter: Jung-Min Ahn September 19, 2022
Presentation TCT 2022 TCT 159: Percutaneous Coronary Intervention of Large Coronary Vessels with the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 4.5/5.0 mm Stent: Primary Outcomes of the EVOLVE Large Vessel Study Presenter: Elissa Altin September 19, 2022
Presentation TCT 2022 TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption Presenter: Gabriele Pesarini September 17, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
Presentation TCT 2021 TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes Presenter: Pasi Karjalainen November 06, 2021
News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021